Gladstone Institute of Cardiovascular Disease, San Francisco, CA 94158, USA; Roddenberry Center for Stem Cell Biology and Medicine at Gladstone, San Francisco, CA 94158, USA.
Center for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan.
Cell Stem Cell. 2014 Jan 2;14(1):40-52. doi: 10.1016/j.stem.2013.11.001. Epub 2013 Nov 14.
Reprogramming differentiated cells into induced pluripotent stem cells (iPSCs) promotes a broad array of cellular changes. Here we show that the let-7 family of microRNAs acts as an inhibitory influence on the reprogramming process through a regulatory pathway involving prodifferentiation factors, including EGR1. Inhibiting let-7 in human cells promotes reprogramming to a comparable extent to c-MYC when combined with OCT4, SOX2, and KLF4, and persistence of let-7 inhibits reprogramming. Inhibiting let-7 during reprogramming leads to an increase in the level of the let-7 target LIN-41/TRIM71, which in turn promotes reprogramming and is important for overcoming the let-7 barrier to reprogramming. Mechanistic studies revealed that LIN-41 regulates a broad array of differentiation genes, and more specifically, inhibits translation of EGR1 through binding its cognate mRNA. Together our findings outline a let-7-based pathway that counteracts the activity of reprogramming factors through promoting the expression of prodifferentiation genes.
重编程分化细胞为诱导多能干细胞(iPSCs)会促进广泛的细胞变化。在这里,我们表明 let-7 微 RNA 家族通过涉及分化前因子(包括 EGR1)的调节途径,对重编程过程起到抑制作用。在人细胞中抑制 let-7,与 OCT4、SOX2 和 KLF4 结合,可促进重编程,达到与 c-MYC 相当的程度,而 let-7 的持续存在则抑制重编程。在重编程过程中抑制 let-7 会导致 let-7 靶标 LIN-41/TRIM71 的水平升高,进而促进重编程,并且对于克服重编程的 let-7 障碍非常重要。机制研究表明,LIN-41 调节广泛的分化基因,更具体地说,通过结合其同源 mRNA 抑制 EGR1 的翻译。总之,我们的研究结果概述了一条基于 let-7 的途径,通过促进分化前基因的表达来抵消重编程因子的活性。